Torrent Pharma to acquire skincare manufacturer Curatio Healthcare: Details

Torrent was not the only pharmaceutical company shortlisted for the acquisition of Curatio; other contenders were Aurobindo, Dr. Reddy's, JB Chemicals, Biocon, and Zydus.

Eventually, as per the reports, the two remaining parties in the race to acquire Chennai-based Curatio were Torrent Pharma and KKR-controlled JB Chemicals.

Curatio, which was set up in 2005, runs through a network of more than 700 distributors and primarily targets dermatologists, paediatricians, and gynaecologists. Tedibar baby soap is its most well-known brand. During the fiscal year 2022, the company reported 240 crore rupees in sales and 60 crore rupees in operating profit. For the current fiscal year, the corporation forecasts 300 crores in revenue and 90 crores in operating profit.

However, in response to the request for clarification regarding the aforementioned agreement, the major pharmaceutical company Torrent Pharmaceutical cited, "It is the company's policy not to respond to any speculative news items. As a growing Company, we do continuously scout for the business opportimities, both organic and. inorganic. As a responsibie listed organization, we inform the Exchanges all events, information which are required to be disclosed in accordance with terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015."